
Part I - Financial Information Item 1. Financial Statements The report presents unaudited consolidated financial statements for the nine months ended September 30, 2020 Consolidated Balance Sheets Total assets grew to $1.51 billion, driven by increases in securities, loans, and deposits Consolidated Balance Sheet Highlights (in thousands) | Account | Sep 30, 2020 | Dec 31, 2019 | | :--- | :--- | :--- | | Total Assets | $1,511,213 | $1,269,157 | | Total cash and cash equivalents | $71,160 | $83,828 | | Debt securities available for sale | $346,473 | $187,433 | | Net Loans | $1,005,807 | $922,609 | | Total Liabilities | $1,371,639 | $1,141,629 | | Total deposits | $1,336,749 | $1,125,392 | | Subordinate notes | $19,547 | $— | | Total Shareholders' Equity | $139,574 | $127,528 | Consolidated Statements of Income Net income declined to $8.2 million for the nine-month period due to a higher provision for loan losses Income Statement Summary (in thousands, except per share data) | Metric | Nine Months Ended Sep 30, 2020 | Nine Months Ended Sep 30, 2019 | | :--- | :--- | :--- | | Net Interest Income | $30,968 | $31,725 | | Provision for loan losses | $5,350 | $237 | | Noninterest Income | $10,903 | $10,342 | | Noninterest Expense | $28,821 | $28,010 | | Net Income | $8,248 | $11,720 | | Diluted Earnings Per Share | $1.89 | $2.66 | Consolidated Statements of Cash Flows Cash and cash equivalents decreased by $12.7 million, as financing activities funded investment purchases Cash Flow Summary for Nine Months Ended Sep 30 (in thousands) | Activity | 2020 | 2019 | | :--- | :--- | :--- | | Net cash provided by operating activities | $2,375 | $14,566 | | Net cash (used in) provided by investing activities | ($242,245) | $12,000 | | Net cash provided by financing activities | $227,202 | $70,611 | | (Decrease) increase in cash and cash equivalents | ($12,668) | $97,177 | Notes to Consolidated Financial Statements Disclosures cover CECL adoption, COVID-19 loan modifications, new debt, and regulatory capital ratios - The Corporation is preparing for the adoption of the new CECL standard, effective January 1, 2023, which is expected to result in earlier recognition of loan loss allowances25 - As of September 30, 2020, the Bank has granted approximately $83 million in loan deferrals (about 8% of gross loans) in response to the COVID-19 pandemic under the CARES Act53 - In Q3 2020, the Corporation issued $20 million of unsecured subordinated debt notes, structured to qualify as Tier 2 Capital79 Regulatory Capital Ratios (Bank) as of Sep 30, 2020 | Ratio | Actual | Well-Capitalized Minimum | | :--- | :--- | :--- | | Common Equity Tier 1 | 13.99% | 6.50% | | Tier 1 Risk-based Capital | 13.99% | 8.00% | | Total Risk-based Capital | 15.25% | 10.00% | | Tier 1 Leverage | 8.61% | 5.00% | Management's Discussion and Analysis (MD&A) Management analyzes financial results, focusing on the pandemic's impact on loan loss provisions and balance sheet changes Results of Operations Net income fell to $8.2 million due to a $5.4 million provision for loan losses related to the COVID-19 pandemic Year-to-Date Performance Summary (in thousands) | Metric | YTD Sep 30, 2020 | YTD Sep 30, 2019 | | :--- | :--- | :--- | | Net Income | $8,248 | $11,720 | | Net Interest Income | $30,968 | $31,725 | | Provision for Loan Losses | $5,350 | $237 | | Noninterest Income | $10,903 | $10,342 | | Noninterest Expense | $28,821 | $28,010 | - The year-to-date provision for loan loss expense increased to $5.4 million due to qualitative factor increases related to the economic effects of the COVID-19 pandemic112 - A tax benefit of $1.1 million was recorded in Q2 2020 due to a CARES Act provision allowing the carryback of a 2018 Net Operating Loss (NOL)115142 Financial Condition Total assets grew to $1.51 billion, funded by a surge in deposits and new subordinated debt - Net loans increased by $83.2 million (9%) in 2020, largely due to $63.4 million in Paycheck Protection Program (PPP) loans117 - Deposits increased by $211.4 million since year-end 2019, attributed to government stimulus payments and lower consumer spending during the pandemic119 - In Q3 2020, the Corporation issued $20.0 million of subordinated notes to enhance regulatory capital and for general corporate purposes120197 Loan Portfolio and Quality Loan quality deteriorated with nonperforming loans rising to 0.93%, driven by downgrades in the hotel portfolio Loan Portfolio Composition (in thousands) | Loan Class | Sep 30, 2020 | Dec 31, 2019 | | :--- | :--- | :--- | | Residential real estate 1-4 family | $200,372 | $190,543 | | Residential real estate - construction | $14,214 | $13,323 | | Commercial real estate | $505,498 | $494,262 | | Commercial (incl. PPP) | $296,331 | $230,007 | | Consumer | $6,543 | $6,440 | | Total Gross Loans | $1,022,958 | $934,575 | Credit Quality Metrics | Metric | Sep 30, 2020 | Dec 31, 2019 | | :--- | :--- | :--- | | Nonperforming loans to total gross loans | 0.93% | 0.42% | | Nonperforming assets to total assets | 0.63% | 0.31% | | Allowance for loan losses to nonperforming loans | 180.31% | 306.43% | - The 'watch list' of loans increased to $48.1 million from $11.6 million at year-end 2019, primarily due to downgrades of hotel loans impacted by the pandemic163 - As of Sep 30, 2020, the Bank had $82.5 million in active loan deferrals under the CARES Act, with the hotel sector comprising the largest portion at $60.8 million175177 Allowance for Loan Losses (ALL) The ALL increased to $17.2 million (1.68% of loans) due to higher qualitative risk factors for the pandemic - The year-to-date increase in the ALL was primarily driven by the qualitative analysis component of the calculation methodology184185186 - Due to the pandemic, the qualitative risk factor for 'economic conditions' was increased to 'very high', and modified loans received a separate, higher risk assessment186 Allowance for Loan Losses (ALL) Summary | Metric | Sep 30, 2020 | Dec 31, 2019 | | :--- | :--- | :--- | | ALL Balance (in thousands) | $17,151 | $11,966 | | ALL as a % of gross loans | 1.68% | 1.28% | | ALL as a % of gross loans (ex-PPP) | 1.79% | N/A | Liquidity and Capital Resources The Corporation maintains strong liquidity with $497.1 million in available funding and well-capitalized ratios Available Liquidity at Sep 30, 2020 (in thousands) | Liquidity Source | Available | | :--- | :--- | | Federal Home Loan Bank | $387,935 | | Federal Reserve Bank Discount Window | $24,786 | | Correspondent Banks | $21,000 | | Paycheck Protection Program Liquidity Facility | $63,395 | | Total | $497,116 | - The Corporation's stock repurchase plan was suspended on March 19, 2020, and no shares were purchased during the third quarter200233 Quantitative and Qualitative Disclosures about Market Risk No material changes in market risk exposure were reported for the first nine months of 2020 - There were no material changes in the Corporation's market risk exposure during the first nine months of 2020218 Controls and Procedures Management concluded that disclosure controls and procedures were effective as of September 30, 2020 - The CEO and CFO concluded that as of September 30, 2020, the Corporation's disclosure controls and procedures are effective219 - No changes were made during the quarter that materially affected internal control over financial reporting219 Part II - Other Information Legal Proceedings Current litigation is not expected to have a material adverse effect on the Corporation's financial position - In management's opinion, the ultimate aggregate liability from all current litigation is not expected to have a material adverse effect on the Corporation's financial position226 Risk Factors Key risks include the uncertain impact of the COVID-19 pandemic and potential liabilities from PPP lending - The COVID-19 pandemic could materially and adversely impact the business through increased credit losses, reduced revenue, and operational disruptions229 - Participation in the PPP exposes the Corporation to litigation risk from applicants regarding its loan processing procedures231 - There is a credit risk that the SBA may deny its guarantee on PPP loans if it finds deficiencies in origination, underwriting, or servicing232 Unregistered Sales of Equity Securities and Use of Proceeds The stock repurchase plan was suspended in March 2020, with no shares repurchased in the third quarter - The stock repurchase plan was suspended on March 19, 2020, and no share purchases were made during the third quarter of 2020233 Other Items and Exhibits The report confirms no defaults on senior securities and lists all filed exhibits, including certifications - The report confirms no defaults on senior securities and lists filed exhibits, including CEO/CFO certifications and XBRL data files234236